AIIMS Delhi to start screening children for Covaxin trials from Monday

The All India Institute of Medical Sciences (AIIMS), Delhi, will start screening children for clinical trials of indigenous home-grown Covid-19 vaccineBharat Biotech‘s Covaxin, from Monday, sources said.

AIIMS Delhi will be starting clinical trials after AIIMS Patna which started the trials recently on children aged between 12 and 18 years old.

After getting permission from the Drugs Controller General of India (DCGI), AIIMS, Delhi is now starting the screening for clinical trials before starting the trials.

To grant the permission of trials, DCGI’s approval was followed by a recommendation on May 12 by a Subject Expert Committee (SEC).

  • Related Posts

    FIR Lodged Against Pharmacist in Chandauli for Working Nearly 10 Years on Forged Documents

    Chandauli – In yet another shocking case of alleged fraud in Uttar Pradesh’s health department, an FIR has been registered against a pharmacist for securing and continuing employment for nearly…

    Laughing all the Way to Health with Sir Ganga Ram Hospital

    The Hospital, Epitome of Best Healthcare, celebrated WLD with JVCC Laughter Club New Delhi: Laughter is the barometer of good health and a medicine too to infuse wellness. On World…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    FIR Lodged Against Pharmacist in Chandauli for Working Nearly 10 Years on Forged Documents

    FIR Lodged Against Pharmacist in Chandauli for Working Nearly 10 Years on Forged Documents

    Laughing all the Way to Health with Sir Ganga Ram Hospital

    Laughing all the Way to Health with Sir Ganga Ram Hospital

    Semaglutide generics ‘stimulating’ Obesity market growth, says Eli Lilly’s Patrik Jonsson

    Semaglutide generics ‘stimulating’ Obesity market growth, says Eli Lilly’s Patrik Jonsson

    Pak-made illegal cosmetics recovered from Itwari shop

    Pak-made illegal cosmetics recovered from Itwari shop

    Licences of 20 medical stores suspended after inspections

    Licences of 20 medical stores suspended after inspections

    Bain Capital sells nearly 1 pc stake in Emcure Pharma for Rs 289 crore

    Bain Capital sells nearly 1 pc  stake in Emcure Pharma for Rs 289 crore